Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States.

Curran D, Patterson B, Varghese L, Van Oorschot D, Buck P, Carrico J, Hicks K, Lee B, Yawn B.

Vaccine. 2018 Aug 9;36(33):5037-5045. doi: 10.1016/j.vaccine.2018.07.005. Epub 2018 Jul 14.

3.
4.

Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective.

Han MK, Martinez CH, Au DH, Bourbeau J, Boyd CM, Branson R, Criner GJ, Kalhan R, Kallstrom TJ, King A, Krishnan JA, Lareau SC, Lee TA, Lindell K, Mannino DM, Martinez FJ, Meldrum C, Press VG, Thomashow B, Tycon L, Sullivan JL, Walsh J, Wilson KC, Wright J, Yawn B, Zueger PM, Bhatt SP, Dransfield MT.

Lancet Respir Med. 2016 Jun;4(6):473-526. doi: 10.1016/S2213-2600(16)00094-1. Epub 2016 May 13. Review.

PMID:
27185520
5.

Concordance between Individual vs. Area-Level Socioeconomic Measures in an Urban Setting.

Narla NP, Pardo-Crespo MR, Beebe TJ, Sloan J, Yawn B, Williams AR, Juhn YJ.

J Health Care Poor Underserved. 2015 Nov;26(4):1157-72. doi: 10.1353/hpu.2015.0122.

PMID:
26548670
6.

COPD9USA June 2015.

Yawn B, Mannino D, Kalhan R, Rennard S, Thomashow B, Walsh J.

Chronic Obstr Pulm Dis. 2015 Sep 16;2(4):343-366. doi: 10.15326/jcopdf.2.4.2015.0147. No abstract available.

7.

The COPD Foundation Pocket Consultant Guide.

Thomashow B, Crapo J, Yawn B, McIvor A, Cerreta S, Walsh J, Mannino D, Rennard S.

Chronic Obstr Pulm Dis. 2014 May 6;1(1):83-87. doi: 10.15326/jcopdf.1.1.2014.0124. Review.

8.
9.

Increasing availability to and ascertaining value of asthma action plans in schools through use of technology and community collaboration.

Hanson TK, Aleman M, Hart L, Yawn B.

J Sch Health. 2013 Dec;83(12):915-20. doi: 10.1111/josh.12110.

PMID:
24261526
10.

Enhancing school asthma action plans: qualitative results from southeast Minnesota beacon stakeholder groups.

Egginton JS, Textor L, Knoebel E, McWilliams D, Aleman M, Yawn B.

J Sch Health. 2013 Dec;83(12):885-95. doi: 10.1111/josh.12107.

PMID:
24261523
11.

Quantifying traffic exposure.

Pratt GC, Parson K, Shinoda N, Lindgren P, Dunlap S, Yawn B, Wollan P, Johnson J.

J Expo Sci Environ Epidemiol. 2014 May-Jun;24(3):290-6. doi: 10.1038/jes.2013.51. Epub 2013 Sep 18.

PMID:
24045427
12.

Shared decision making for patients with type 2 diabetes: a randomized trial in primary care.

Branda ME, LeBlanc A, Shah ND, Tiedje K, Ruud K, Van Houten H, Pencille L, Kurland M, Yawn B, Montori VM.

BMC Health Serv Res. 2013 Aug 8;13:301. doi: 10.1186/1472-6963-13-301.

13.

Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, recommendations of the COPD Foundation.

Rennard S, Thomashow B, Crapo J, Yawn B, McIvor A, Cerreta S, Walsh J, Mannino D.

COPD. 2013 Jun;10(3):378-89. doi: 10.3109/15412555.2013.801309.

PMID:
23713598
14.

Increased risk of herpes zoster in children with asthma: a population-based case-control study.

Kim BS, Mehra S, Yawn B, Grose C, Tarrell R, Lahr B, Juhn YJ.

J Pediatr. 2013 Sep;163(3):816-21. doi: 10.1016/j.jpeds.2013.03.010. Epub 2013 Apr 13.

15.

Underestimation of liver-related mortality in the United States.

Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR.

Gastroenterology. 2013 Aug;145(2):375-82.e1-2. doi: 10.1053/j.gastro.2013.04.005. Epub 2013 Apr 9.

16.

Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care.

Azevedo P, Correia de Sousa J, Bousquet J, Bugalho-Almeida A, Del Giacco SR, Demoly P, Haahtela T, Jacinto T, Garcia-Larsen V, van der Molen T, Morais-Almeida M, Nogueira-Silva L, Pereira AM, Rodríguez MR, Silva BG, Tsiligianni IG, Yaman H, Yawn B, Fonseca JA; WHO Collaborative Center for Asthma and Rhinitis, Montpellier.

Prim Care Respir J. 2013 Mar;22(1):112-6. doi: 10.4104/pcrj.2013.00012.

17.

How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Fabbri LM, Boyd C, Boschetto P, Rabe KF, Buist AS, Yawn B, Leff B, Kent DM, Schünemann HJ; ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development.

Proc Am Thorac Soc. 2012 Dec;9(5):274-81. doi: 10.1513/pats.201208-063ST. Review.

18.

Inflammation in COPD: implications for management.

Sethi S, Mahler DA, Marcus P, Owen CA, Yawn B, Rennard S.

Am J Med. 2012 Dec;125(12):1162-70. doi: 10.1016/j.amjmed.2012.06.024. Review.

PMID:
23164484
19.

Incidence, secular trends, and outcomes of prosthetic joint infection: a population-based study, olmsted county, Minnesota, 1969-2007.

Tsaras G, Osmon DR, Mabry T, Lahr B, St Sauveur J, Yawn B, Kurland R, Berbari EF.

Infect Control Hosp Epidemiol. 2012 Dec;33(12):1207-12. doi: 10.1086/668421. Epub 2012 Oct 23.

20.

Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD.

Price D, Yawn B, Brusselle G, Rossi A.

Prim Care Respir J. 2013 Mar;22(1):92-100. doi: 10.4104/pcrj.2012.00092. Review.

Supplemental Content

Loading ...
Support Center